HPLC Analysis of Valsartan

Valsartan is a drug commonly used to treat high blood pressure and congestive heart failure. Legacy L1 was used to retain valsartan by reverse phase mechanism in this HPLC separation method. Legacy L1 uses embedded C18 groups on porous silica and is useful for many USP HPLC applications. Comparisons to Phenomenex columns are available by request. This simple HPLC method can be used in many pharmaceutical areas. For example, in batch production, impurity profiling, formulation and pharmacokinetics.

Condition
Column Legacy L1, 4.6×250 mm, 5 µm, 100A
Mobile Phase MeCN – 50%
Buffer NaH2PO4  pH 2.5 – 20 mM
Flow Rate 1.0 ml/min
Detection UV, 254 nm

 

 

Description
Class of Compounds
  Drug,  Hydrophilic, Ionizable
Analyzing Compounds Valsartan

 

Application Column

SIELC Legacy L1 HPLC column

Legacy L1

SIELC's family of Legacy columns is based on the United States Pharmacopeia's (USP) published chromatographic methods and procedures. Numerous brands have columns used in USP reference standards and methods. USP has created various designations to group together columns with similar types of packing and properties in the solid phase. SIELC's Legacy columns adhere to these strict requirements and properties, allowing you to easily replace older columns that are no longer available without needing to significantly modify your method or SOPs.

Select options
Application Analytes:
Valsartan
Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.